Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 74 holding rows worth $222,197,000.

Accession
0001140361-15-041494
Filed
2015-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 74 entries on the cover page, a total value of $222,197,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $222,197,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALLERGAN PLCG0177J108SHS37,500$10,193,000thousands by filing date
NUVASIVE INC670704105COM175,000$8,439,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock500,000$7,695,000thousands by filing date
Mallinckrodt PlcG5785G107SHS120,000$7,673,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM235,000$7,527,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM450,000$7,200,000thousands by filing date
Amgen Inc.031162100COM50,000$6,916,000thousands by filing date
Gilead Sciences,Inc.375558103COM70,000$6,873,000thousands by filing date
CELGENE CORP151020104COM60,000$6,490,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC02043Q907CALL75,000$6,027,000thousands by filing datecall
BRISTOL-MYERS SQUIBB CO110122908CALL100,000$5,920,000thousands by filing datecall
FLAMEL TECHNOLOGIES-SP ADR338488109SPON350,000$5,709,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock40,000$5,687,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS275,000$5,451,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK120,000$5,132,000thousands by filing date
ZOGENIX INC.98978L204Common Stock370,000$4,995,000thousands by filing date
HEARTWARE INTL INC422368100COM90,000$4,708,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW75,000$4,466,000thousands by filing date
Alcobra LtdM2239P109SHS688,961$4,161,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM525,000$4,132,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM165,000$4,049,000thousands by filing date
HCA Healthcare Inc40412C101COM50,000$3,868,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM250,000$3,400,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock80,000$3,288,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM7,000$3,217,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW600,000$3,180,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock100,000$3,144,000thousands by filing date
UNIQURE NVN90064101SHS150,000$3,068,000thousands by filing date
SPECTRANETICS CORP84760C107COM250,000$2,948,000thousands by filing date
THERAPEUTICSMD INC88338N907COM500,000$2,930,000thousands by filing datecall
BELLICUM PHARMACEUTICALS INC079481107COM200,000$2,906,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR175,000$2,830,000thousands by filing date
INCYTE CORP COM45337C102Stock25,000$2,758,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM250,000$2,753,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS30,000$2,741,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM100,000$2,651,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock225,000$2,565,000thousands by filing date
HERON THERAPEUTICS INC427746902COM100,000$2,440,000thousands by filing datecall
RELYPSA INC759531106Common Stock120,000$2,221,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM55,000$2,188,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW398,300$2,107,000thousands by filing date
ZAFGEN INC98885E103COM65,000$2,077,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM300,000$2,073,000thousands by filing date
NEURODERM LTDM74231107ORD SHS100,000$2,067,000thousands by filing date
PTC THERAPEUTICS INC69366J900COM75,000$2,003,000thousands by filing datecall
CELLECTIS ADS15117K103COM75,000$1,977,000thousands by filing date
EPIZYME INC29428V104COM150,000$1,929,000thousands by filing date
Lion Biotechnologies53619R102COM300,000$1,728,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM40,800$1,727,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR97,135$1,719,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM220,000$1,507,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01300,000$1,413,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock40,000$1,323,000thousands by filing date
REGENXBIO INC75901B107COM60,000$1,322,000thousands by filing date
CHIASMA INC16706W102COM65,000$1,292,000thousands by filing date
CORIUM INTL INC21887L107COM125,000$1,169,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS150,000$1,100,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock25,000$1,066,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM350,000$1,050,000thousands by filing date
VERACYTE INC COM92337F107Stock202,800$951,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM400,000$776,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J906COM106,200$590,000thousands by filing datecall
BIODELIVERY SCIENCES INTL IN09060J106COM100,000$556,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK6,500$490,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR20,325$488,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM89,231$476,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM10,000$417,000thousands by filing date
Adobe Systems Inc98979H103COM100,000$396,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM125,000$395,000thousands by filing date
UNILIFE CORP NEW90478E103COM350,000$343,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM10,000$321,000thousands by filing date
RAPTOR PHARMACEUTICAL CORP75382F106COM50,000$303,000thousands by filing date
BIOLASE INC090911108COMMON STOCK300,000$270,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW292,939$237,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-041494this filing2015-11-16acceptance time not in the bulk data set